Search Results for: PDE4DIP

76 interactions involving PDE4DIP - phosphodiesterase 4D interacting protein found:

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ADH1B alcohol dehydrogenase 1B (class I), beta polypeptide
  • Ethanol oxidation
  • NADH
  • Fomepizole
  • N-Benzylformamide
  • 4-Iodopyrazole
  • 2'-Monophosphoadenosine 5'-Diphosphoribose
  • Cyclohexanol
  • N-Heptylformamide
  • Glycerin
AEN apoptosis enhancing nuclease
ANKRD11 ankyrin repeat domain 11
ARNT2 aryl hydrocarbon receptor nuclear translocator 2
  • PPARA activates gene expression
  • Phase I - Functionalization of compounds
  • Endogenous sterols
  • Xenobiotics
  • Aryl hydrocarbon receptor signalling
BYSL bystin like
  • Major pathway of rRNA processing in the nucleolus and cytosol
C1orf109 chromosome 1 open reading frame 109
CCDC146 coiled-coil domain containing 146
CCDC198 coiled-coil domain containing 198
CDC5L cell division cycle 5 like
  • mRNA Splicing - Major Pathway
CDKN1A cyclin dependent kinase inhibitor 1A
  • SCF(Skp2)-mediated degradation of p27/p21
  • AKT phosphorylates targets in the cytosol
  • Senescence-Associated Secretory Phenotype (SASP)
  • DNA Damage/Telomere Stress Induced Senescence
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • Cyclin D associated events in G1
  • p53-Dependent G1 DNA Damage Response
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • TFAP2 (AP-2) family regulates transcription of cell cycle factors
  • Transcriptional regulation by RUNX2
  • RUNX3 regulates CDKN1A transcription
  • Transcriptional regulation of granulopoiesis
  • FOXO-mediated transcription of cell cycle genes
  • Arsenic trioxide
  • Cervical cancer
CHCHD3 coiled-coil-helix-coiled-coil-helix domain containing 3
  • Mitochondrial protein import
  • Cristae formation
CHD1L chromodomain helicase DNA binding protein 1 like
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
EGR2 early growth response 2
  • Transcriptional regulation of white adipocyte differentiation
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
EIF4E2 eukaryotic translation initiation factor 4E family member 2
  • ISG15 antiviral mechanism
FAM161A FAM161 centrosomal protein A
  • Retinitis pigmentosa (RP)
FAM74A4 family with sequence similarity 74 member A4
FCHSD2 FCH and double SH3 domains 2
FES FES proto-oncogene, tyrosine kinase
  • Signaling by SCF-KIT
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
FHL1 four and a half LIM domains 1
  • X-linked myopathy with postural muscle atrophy (XMPMA)
  • Reducing body myopathy (RBM)
  • Scapuloperoneal myopathy (SPM)
  • Emery-Dreifuss muscular dystrophy
GADD45G growth arrest and DNA damage inducible gamma
GBE1 1,4-alpha-glucan branching enzyme 1
  • Glycogen synthesis
  • Glycogen storage disease type IV (GBE1)
  • Glycogen storage diseases (GSD), including: von Gierke disease (GSD type Ia); Pompe disease (GSD type II); Cori disease, Forbe disease (GSD type III); Andersen disease (GSD type IV); McArdle disease (GSD type V); Hers disease (GSD type VI); Tarui disease (GSD type VII); Phosphorylase kinase deficiency (GSD type IX); Fanconi-Bickel syndrome (GSD type XI); Glycogen synthase deficiency (GSD type 0)
GFI1B growth factor independent 1B transcriptional repressor
GNRHR2 gonadotropin releasing hormone receptor 2 (pseudogene)
GOLGA5 golgin A5
  • Intra-Golgi traffic
GOLGA8EP golgin A8 family member E, pseudogene
GOLGA8F golgin A8 family member F
HAUS1 HAUS augmin like complex subunit 1
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
IMMT inner membrane mitochondrial protein
  • Cristae formation
ITSN2 intersectin 2
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
KDM1A lysine demethylase 1A
  • HDACs deacetylate histones
  • HDMs demethylate histones
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • Regulation of PTEN gene transcription
  • Estrogen-dependent gene expression
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • Factors involved in megakaryocyte development and platelet production
KLC3 kinesin light chain 3
  • MHC class II antigen presentation
  • RHO GTPases activate KTN1
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Kinesins
KLC4 kinesin light chain 4
  • MHC class II antigen presentation
  • RHO GTPases activate KTN1
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Kinesins
KRAS KRAS proto-oncogene, GTPase
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • RUNX3 regulates p14-ARF
  • RAS GTPase cycle mutants
  • Signaling downstream of RAS mutants
  • [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID
  • FARNESYL DIPHOSPHATE
  • Craniosynostosis, including: Pfeiffer syndrome; Apert syndrome; Crouzon syndrome; Jackson-Weiss syndrome; Beare-Stevenson syndrome; Muenke craniosynostosis; Saethre-Chotzen syndrome; Craniosynostosis Boston type; Antley-Bixler syndrome; Carpenter syndrome; Craniofrontonasal dysplasia; Noonan syndrome; Baller-Gerold syndrome
  • Pancreatic cancer
  • Gastric cancer
  • Colorectal cancer
  • Non-small cell lung cancer
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
  • Oral cancer
  • Acute myeloid leukemia (AML)
  • Endometrial Cancer
  • Multiple myeloma
  • Squamous cell carcinoma
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Thyroid cancer
  • Cervical cancer
  • Hepatocellular carcinoma
  • Ovarian cancer
  • Gallbladder cancer
KRT1 keratin 1
  • Neutrophil degranulation
  • Keratinization
  • Formation of the cornified envelope
  • Zinc
  • Copper
  • Epidermolytic palmoplantar keratoderma (EPPK)
  • Ichthyosis hystrix, Curth-Macklin type
  • Epidermolytic hyperkeratosis (EHK); Bullous congenital ichthyosiform erythroderma (BCIE)
  • Striate palmoplantar keratoderma
KRT18 keratin 18
  • Keratinization
  • Formation of the cornified envelope
KRT31 keratin 31
  • Keratinization
  • Formation of the cornified envelope
LAMTOR3 late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
  • Macroautophagy
  • mTOR signalling
  • mTORC1-mediated signalling
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • MAP2K and MAPK activation
  • Neutrophil degranulation
  • Regulation of PTEN gene transcription
  • Amino acids regulate mTORC1
LENG1 leukocyte receptor cluster member 1
LMO4 LIM domain only 4
MIF4GD MIF4G domain containing
MTUS2 microtubule associated scaffold protein 2
NAA10 N-alpha-acetyltransferase 10, NatA catalytic subunit
NEFL neurofilament light
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • RAF/MAP kinase cascade
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
NEK2 NIMA related kinase 2
  • APC-Cdc20 mediated degradation of Nek2A
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
  • 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE
OSGEP O-sialoglycoprotein endopeptidase
  • tRNA modification in the nucleus and cytosol
PDE4D phosphodiesterase 4D
  • DARPP-32 events
  • G alpha (s) signalling events
  • Adenosine monophosphate
  • Caffeine
  • Dyphylline
  • Iloprost
  • Roflumilast
  • Piclamilast
  • Rolipram
  • 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol
  • 6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One
  • 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • (S)-Rolipram
  • Cilomilast
  • (R)-Rolipram
  • 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester
  • Crisaborole
  • Ibudilast
  • Tetomilast
  • Apremilast
  • (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
  • 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
  • 3-isobutyl-1-methyl-7H-xanthine
  • 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
  • Trapidil
PEA15 proliferation and apoptosis adaptor protein 15
  • RAF-independent MAPK1/3 activation
  • RAF/MAP kinase cascade
PFDN1 prefoldin subunit 1
  • Prefoldin mediated transfer of substrate to CCT/TriC
PIAS4 protein inhibitor of activated STAT 4
  • Vitamin D (calciferol) metabolism
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of DNA replication proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • G2/M DNA damage checkpoint
PPP1R18 protein phosphatase 1 regulatory subunit 18
PRNP prion protein
  • NCAM1 interactions
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Tetracycline
  • Copper
  • Prion diseases; Creutzfeldt-Jacob disease (CJD); Gerstmann-Straussler disease (GSD); Gerstmann-Straussler-Scheinker disease (GSSD); Fatal familial insomnia (FFI)
PRPF31 pre-mRNA processing factor 31
  • mRNA Splicing - Major Pathway
  • Retinitis pigmentosa (RP)
RBM8A RNA binding motif protein 8A
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA Splicing - Major Pathway
  • mRNA 3'-end processing
  • RNA Polymerase II Transcription Termination
  • Regulation of expression of SLITs and ROBOs
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
RTP5 receptor transporter protein 5 (putative)
  • Olfactory Signaling Pathway
SCNM1 sodium channel modifier 1
SDCBP syndecan binding protein
  • Ephrin signaling
  • Neurofascin interactions
  • Neutrophil degranulation
SH2D4A SH2 domain containing 4A
SHFL shiftless antiviral inhibitor of ribosomal frameshifting
SMN1 survival of motor neuron 1, telomeric
  • snRNP Assembly
  • Nusinersen
  • Spinal muscular atrophy (SMA), including: SMA type I (SMA1) / Werdning-Hoffman disease; SMA type II (SMA2); SMA type III (SMA3) / Kugeleberg-Welander disease; SMA type IV (SMA4); X-linked SMA 2 (SMAX2); X-linked distal SMA 3 (DSMAX); Distal SMA autosomal recessive type 4 (DSMA4); Congenital distal spinal muscular atrophy (SMAL); SMA proximal adult autosomal dominant (SMAPAD)
SNCA synuclein alpha
  • Amyloid fiber formation
  • Resveratrol
  • Copper
  • Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
  • Parkinson's disease (PD)
TEAD4 TEA domain transcription factor 4
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • RUNX3 regulates YAP1-mediated transcription
TFIP11 tuftelin interacting protein 11
  • mRNA Splicing - Major Pathway
THRB thyroid hormone receptor beta
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Liothyronine
  • Levothyroxine
  • Dextrothyroxine
  • Amiodarone
  • Liotrix
  • [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid
  • 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid
  • 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione
  • Tiratricol
  • GC-24
  • Eprotirome
  • MB07811
  • Sobetirome
  • 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
TK1 thymidine kinase 1
  • G1/S-Specific Transcription
  • Pyrimidine salvage
  • Dithioerythritol
  • Thymidine-5'-Triphosphate
TMOD4 tropomodulin 4
  • Striated Muscle Contraction
TNIK TRAF2 and NCK interacting kinase
  • Oxidative Stress Induced Senescence
TRAF4 TNF receptor associated factor 4
UTP14C UTP14C small subunit processome component
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
VAC14 VAC14 component of PIKFYVE complex
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the early endosome membrane
  • Synthesis of PIPs at the early endosome membrane
  • Synthesis of PIPs at the late endosome membrane
  • Synthesis of PIPs at the late endosome membrane
ZBTB38 zinc finger and BTB domain containing 38
ZDHHC17 zinc finger DHHC-type palmitoyltransferase 17
ZFYVE21 zinc finger FYVE-type containing 21
ZNF408 zinc finger protein 408
ZNF512B zinc finger protein 512B
ZNF581 zinc finger protein 581
ZSCAN26 zinc finger and SCAN domain containing 26